Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.

about

Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment

P2860

Q44723040-9452F872-937B-4EA7-89EA-FCC6A0DC0E22 Q57214335-EE001BC2-462B-49E7-8CC9-EFA3B5E4AD81

P2860

Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.

Item

http://www.wikidata.org/entity/Q50887645

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characterization and antitumor efficacy of poly

@nl

Characterization and antitumor ...... sed etoposide-loaded implants.

@en

type

Item

label

Characterization and antitumor efficacy of poly

@nl

Characterization and antitumor ...... sed etoposide-loaded implants.

@en

prefLabel

Characterization and antitumor efficacy of poly

@nl

Characterization and antitumor ...... sed etoposide-loaded implants.

@en

P1476

Characterization and antitumor ...... sed etoposide-loaded implants.

@en

P2093

Chuanqi Xie

http://www.w3.org/2001/XMLSchema#string

Erkang Xuan

http://www.w3.org/2001/XMLSchema#string

Jianjian Xu

http://www.w3.org/2001/XMLSchema#string

Lan Luo

http://www.w3.org/2001/XMLSchema#string

Li Gao

http://www.w3.org/2001/XMLSchema#string

Xiaodong Wang

http://www.w3.org/2001/XMLSchema#string

Xiuxiu Liu

http://www.w3.org/2001/XMLSchema#string

Yang Zhao

http://www.w3.org/2001/XMLSchema#string

Yuzhi Du

http://www.w3.org/2001/XMLSchema#string

P2860

Etoposide: four decades of development of a topoisomerase II inhibitor

Cancer statistics, 2016

High interstitial fluid pressure - an obstacle in cancer therapy

Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy

The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC).

Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro.

Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model

Solubilizing excipients in oral and injectable formulations.

Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor

Fluorouracil implants caused a diaphragmatic tumor to be misdiagnosed as liver metastasis: a case report.

P304

765-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10717544.2017.1321063

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28475414

http://www.w3.org/2001/XMLSchema#string

Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.

about

P2860

P2860

Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698